Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects
Clinical trial NCT03980080 · COMPLETED
Trial details
- NCT number
- NCT03980080
- Sponsor
- OSE Immunotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2019-11-04
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.